Major Depression

See Our Other Current Trials >


Major Depression is a long-term illness for many patients and maintenance therapy is recommended to prevent relapse in patients with recurrent depression.  This study is being conducted to evaluate the efficacy of vortioxetine in the prevention of relapse in subjects with Major Depression.

To Qualify:

  • Age Group: 18 to 75 Years Old

Register for This Trial